SynGAP Research Fund General Research Grants

SynGAP Research Fund General Research Grants

Funder: SynGAP Research Fund (SRF), a 501(c)(3) public charity incorporated in the US in 2018

Mission: Improve the quality of life for SYNGAP1 patients through the research and development of treatments, therapies and support systems

Geographic Scope: International (US headquarters in Palo Alto, California; sister organizations in UK (2020) and Europe/Netherlands (2022))

Key Information

• Status: Active; SRF is the largest non-government funder of SynGAP research
• Commitment: Over $3M in grants committed as of 2022
• Operational Model: Founders cover all operational costs, allowing 100% of donations to go to research
• Grant Duration: One or two-year grants

Eligibility

• Young investigators
• Physician residents
• Clinicians interested in studying SYNGAP1

Focus Areas

• Novel ideas related to SYNGAP1
• Clinical aspects of SYNGAP1
• Therapies for SYNGAP1
• Genetic causes of SYNGAP1
• Research on SYNGAP1-related intellectual disability, epilepsy, autism, and associated neurological conditions

About SYNGAP1

SYNGAP1-related intellectual disability (ICD-10 F78.A1) is a rare genetic disorder caused by variants on the SYNGAP1 gene (Chromosome 6). The disorder leads to neurological issues including:
• Intellectual disability
• Epilepsy
• Hypotonia (low muscle tone)
• Gross and fine motor skill delays
• Autism spectrum disorder
• Gastro-intestinal disorders
• Sleep and behavior disorders
• Visual abnormalities

Contact

• Website: SyngapResearchFund.org
• Social Media: @cureSYNGAP1

Partnerships